Name: TSLA Stalls on China Sales, CEG Sells Off, VKTX's Promising Weight Loss Drug Trial
Uploaded: 2024-11-04T15:06:53.613-06:00
Duration: 9 min 47 s
Description: After Tesla's (TSLA) earnings ripped the stock to the upside, lower-than-expected EV sales in China continued a notable downtrend since its report. Constellation Energy (CEG) sold off when its guidance didn't reach expectations, while Viking Therapeutics (VKTX) rallied off positive trial results from its weight loss drug. George Tsilis dives into the morning's top stories.

Morning Movers

Opening Bell With Nicole Petallides

Morning Trade Live

Trading 360

Fast Market

Next Gen Investing

The Watch List

Market On Close

Market Overtime

Inside the Mind of a Trader

Your First Trade

The Wrap

Liz Ann Live

Schwab 2026 Outlook

<p>Sam Vadas takes traders beyond the headlines with a sharp focus on the macro drivers, sector rotations, and global forces shaping the day’s market action. From breaking down U.S. and international economic data to analyzing sector performance and cross-asset moves, Morning Trade Live delivers the context traders need to understand the “why” behind early trading activity.</p>

Daily insights for every investor

Schwab Network's Newsletters

<p>After Tesla's (TSLA) earnings ripped the stock to the upside, lower-than-expected EV sales in China continued a notable downtrend since its report. Constellation Energy (CEG) sold off when its guidance didn't reach expectations, while Viking Therapeutics (VKTX) rallied off positive trial results from its weight loss drug. George Tsilis dives into the morning's top stories.</p>

TSLA Stalls on China Sales, CEG Sells Off, VKTX's Promising Weight Loss Drug Trial

Expert commentary about top moving stocks, sectors, and commodities, along with CEO and analyst interviews.

Market News